#Anavex Life Sciences (AVXL)

Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease

Anavex Life Sciences Corp Today, January 13, 2026, Anavex Life Sciences Corp. ( AVXL ) announced its participation as a key industry partner in ACCESS-AD, a major new European initiative designed to a...

P

Prohost Biotech

Jan 13, 2026

Our Prohost Small Test and Anavex Life Sciences Earning Report

Anavex Life Sciences Below Today is the earnings report day for Anavex Life Sciences ( AVXL ) and Biogen ( BIIB ) . We are posting the news from Anavex Life Sciences and will continue to study the BII...

P

Prohost Biotech

Feb 12, 2025

Anavex Life Sciences: Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial

Anavex Life Sciences Anavex Life Sciences ( AVXL ) presented new data from the Phase IIb/III study showing that blarcamesine (ANAVEX®2-73), once daily orally, demonstrates pre-specified clinical effic...

P

Prohost Biotech

Nov 1, 2024

Anavex Life Sciences: Phase IIb/III Trial Results of Blarcamesine Presented at Alzheimer's Association Conference

Anaves Life Sciences Trial Results of Blarcamesine Anavex Life Sciences ( AVXL ) presented comprehensive results from a Phase IIb/III study showing that blarcamesine (ANAVEX®2-73), once daily orally,...

P

Prohost Biotech

Jul 29, 2024

Anavex Life Sciences Product Blarcamesine for Alzheimer’s Disease Receives Promising News from the EMA

Anavex Life Sciences Promising News From Anavex Life Sciences ( AVXL ) we learned that The Committee for Medicinal Products for Human Use ( CHMP ) within the European Medicines agency ( EMA ) agreed...

P

Prohost Biotech

Dec 20, 2023

Anavex Announced US Patent Office Granted a Patent No. 11,813.242 Entitled A273 a Therapeutic for Insomnia, Anxiety and Agitation

Anavex Life Sciences Granted US Patent Anavex Life Sciences ( AVXL ) – a development-stage biopharmaceutical company announced that the United States Patent and Trademark Office ( USPTO ) granted U.S....

P

Prohost Biotech

Nov 22, 2023

Anavex Life Sciences Reports Publication in Scientific Journal Demonstrating the Potential of Anavex®3-71 in Preventing Cognitive Decline in Alzheimer's Disease

Anavex Life Sciences NEWS Anavex Life Sciences ( AVXL ) reported a new peer reviewed publication in journal Neurobiology of Aging , titled “ Early treatment with an M1 and sigma 1 receptor agonist pr...

P

Prohost Biotech

Oct 26, 2023

GILD, THRX, AGEN, ENTA, SNTA and AVXL

We have news – a lot of news. But which of which is worth dealing with as worth the time of the reader? Readers’ time is a responsibility that we seriously consider a priority. In the latest issue #3...

P

Prohost Biotech

Nov 18, 2013

1m

16